Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Osborn

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic ExperienceMelva E Pinn, Douglas G Gold, Ivy A Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2007
Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severityDouglas G Gold, Robert C Miller, Melva E Pinn, et al.
Radiation Oncology (London, England)|February 21, 2012
Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control studyAjaykumar B Patel, Christopher L Hallemeier, Ivy A Petersen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 15, 2009
Renal involvement in primary Sjögren's syndrome: a clinicopathologic studySaugar Maripuri, Joseph P Grande, Thomas G Osborn, et al.
Respiratory Medicine|February 12, 2015
Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control studyPhilippe R Bauer, Sanjay Kalra, Thomas G Osborn, et al.
Mayo Clinic Proceedings|July 6, 2020
Cardiovascular Risk Factors and Atherosclerotic Cardiovascular Events Among Incident Cases of Systemic Sclerosis: Results From a Population-Based Cohort (1980-2016)Reto D Kurmann, Avneek S Sandhu, Cynthia S Crowson, et al.
The Journal of Rheumatology|November 16, 2020
Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980-2016)Caitrin M Coffey, Avneek S Sandhu, Cynthia S Crowson, et al.
Chest|March 2, 2013
Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort studyPhilippe R Bauer, Dante N Schiavo, Thomas G Osborn, et al.
Journal of Scleroderma and Related Disorders|March 17, 2022
Systemic Sclerosis Portends Increased Risk of Conduction and Rhythm Abnormalities at Diagnosis and During Disease Course: A US Population-Based CohortYasser A Radwan, Reto D Kurmann, Avneek S Sandhu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic ExperienceMelva E Pinn, Douglas G Gold, Ivy A Petersen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2007
Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severityDouglas G Gold, Robert C Miller, Melva E Pinn, et al.
Radiation Oncology (London, England)|February 21, 2012
Acute and late toxicities of radiotherapy for patients with discoid lupus erythematosus: a retrospective case-control studyAjaykumar B Patel, Christopher L Hallemeier, Ivy A Petersen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 15, 2009
Renal involvement in primary Sjögren's syndrome: a clinicopathologic studySaugar Maripuri, Joseph P Grande, Thomas G Osborn, et al.
Respiratory Medicine|February 12, 2015
Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control studyPhilippe R Bauer, Sanjay Kalra, Thomas G Osborn, et al.
Mayo Clinic Proceedings|July 6, 2020
Cardiovascular Risk Factors and Atherosclerotic Cardiovascular Events Among Incident Cases of Systemic Sclerosis: Results From a Population-Based Cohort (1980-2016)Reto D Kurmann, Avneek S Sandhu, Cynthia S Crowson, et al.
The Journal of Rheumatology|November 16, 2020
Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980-2016)Caitrin M Coffey, Avneek S Sandhu, Cynthia S Crowson, et al.
Chest|March 2, 2013
Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort studyPhilippe R Bauer, Dante N Schiavo, Thomas G Osborn, et al.
Journal of Scleroderma and Related Disorders|March 17, 2022
Systemic Sclerosis Portends Increased Risk of Conduction and Rhythm Abnormalities at Diagnosis and During Disease Course: A US Population-Based CohortYasser A Radwan, Reto D Kurmann, Avneek S Sandhu, et al.
Pageof 2